FEDERATED HERMES, INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,782,842
+8.1%
64,666
+17.8%
0.01%
+25.0%
Q2 2023$1,649,993
-44.5%
54,890
-33.2%
0.00%
-42.9%
Q1 2023$2,975,244
+144.5%
82,121
+140.7%
0.01%
+133.3%
Q4 2022$1,216,918
+1.4%
34,116
-3.7%
0.00%
-25.0%
Q3 2022$1,200,000
+29900.0%
35,443
+28483.1%
0.00%
Q2 2022$4,000
-99.9%
124
-99.9%
0.00%
-100.0%
Q1 2022$4,083,000
+5.9%
126,330
-4.4%
0.01%
+28.6%
Q4 2021$3,855,000
-24.9%
132,193
-32.5%
0.01%
-30.0%
Q1 2021$5,130,000
+12.4%
195,947
+8.0%
0.01%
+11.1%
Q4 2020$4,566,000
+20.8%
181,467
+0.0%
0.01%0.0%
Q3 2020$3,781,000
+230.5%
181,416
+276.7%
0.01%
+200.0%
Q2 2020$1,144,000
-75.3%
48,161
-75.3%
0.00%
-70.0%
Q4 2019$4,626,000
-40.2%
195,025
-30.8%
0.01%
-47.4%
Q3 2019$7,740,000
+56.2%
281,667
+88.1%
0.02%
+58.3%
Q2 2019$4,955,000
+375.1%
149,732
+403.2%
0.01%
+300.0%
Q1 2019$1,043,000
-89.7%
29,758
-82.4%
0.00%
-90.0%
Q2 2018$10,099,000
+615.2%
168,735
+447.4%
0.03%
+650.0%
Q1 2018$1,412,000
+2214.8%
30,826
+1918.7%
0.00%
Q4 2017$61,000
-94.8%
1,527
-94.8%
0.00%
-100.0%
Q3 2017$1,170,000
+1525.0%
29,238
+1652.9%
0.00%
Q2 2017$72,000
+24.1%
1,668
-10.5%
0.00%
Q1 2017$58,000
+7.4%
1,863
-12.9%
0.00%
Q4 2016$54,000
-15.6%
2,140
-17.6%
0.00%
Q3 2016$64,000
+8.5%
2,598
-10.7%
0.00%
Q2 2016$59,000
-15.7%
2,909
-36.8%
0.00%
Q1 2016$70,000
+42.9%
4,602
+25.3%
0.00%
Q4 2015$49,0003,6730.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders